INDOCO REMEDIES
Back to Balance Sheet
|
INDOCO REMEDIES Last 5 Year Short Term Loans and Advances History
[Consolidated]
Mar2024 | Mar2023 | Mar2022 | Mar2021 | Mar2020 | |
---|---|---|---|---|---|
Short Term Loans and Advances | ₹155 Cr | ₹97 Cr | ₹205 Cr | ₹125 Cr | ₹98 Cr |
What is the latest Short Term Loans and Advances ratio of INDOCO REMEDIES ?
Year | Short Term Loans and Advances |
---|---|
Mar2024 | ₹155 Cr |
Mar2023 | ₹97 Cr |
Mar2022 | ₹205 Cr |
Mar2021 | ₹125 Cr |
Mar2020 | ₹98 Cr |
How is Short Term Loans and Advances of INDOCO REMEDIES Trending?
Years | Short Term Loans and Advances | % Change | |
---|---|---|---|
Mar2024 | ₹155 Cr | 60.00 | |
Mar2023 | ₹97 Cr | -52.77 | |
Mar2022 | ₹205 Cr | 64.34 | |
Mar2021 | ₹125 Cr | 27.68 | |
Mar2020 | ₹98 Cr | - |
Compare Short Term Loans and Advances of peers of INDOCO REMEDIES
Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
INDOCO REMEDIES | ₹3,062.9 Cr | -0.8% | 5.2% | -16.7% | Stock Analytics | |
SUN PHARMACEUTICAL INDUSTRIES | ₹446,684.0 Cr | 1% | 4.6% | 47.5% | Stock Analytics | |
DIVIS LABORATORIES | ₹155,935.0 Cr | 1% | -3.2% | 59.3% | Stock Analytics | |
CIPLA | ₹121,639.0 Cr | -1.1% | -0.3% | 20.7% | Stock Analytics | |
DR REDDYS LABORATORIES | ₹115,931.0 Cr | 2.2% | 12.1% | 21.6% | Stock Analytics | |
ZYDUS LIFESCIENCES | ₹97,876.4 Cr | -2.7% | 0.8% | 43.8% | Stock Analytics |
INDOCO REMEDIES Share Price vs Sensex
Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
INDOCO REMEDIES | -0.8% |
5.2% |
-16.7% |
SENSEX | -2.1% |
-2% |
11.3% |
You may also like the below Video Courses